Teleflex Reports $1.99 Billion Revenue for 2025, Announces Restructuring

Teleflex Incorporated

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) reported revenue of $1.99 billion from continuing operations for 2025, a 17.2 percent increase from the prior year, as the medical technology company announced a restructuring plan tied to planned divestitures.

The company reported GAAP diluted earnings per share from continuing operations of $1.31 for 2025, compared with $1.21 in the previous year.

Adjusted diluted earnings per share from continuing operations rose to $6.98 from $6.42 a year earlier, according to the company.

Teleflex said it expects revenue growth from continuing operations in 2026 of 14.40 percent to 15.40 percent on a GAAP basis.

The company forecasts adjusted diluted earnings per share from continuing operations in a range of $6.25 to $6.55 for 2026.

READ:  Smart Sand Reports Fourth-Quarter And Full-Year 2025 Results

Interim President and Chief Executive Officer Stuart Randle said the company is restructuring its operations as part of broader portfolio changes.

“Teleflex is in the midst of a transformation that optimizes our portfolio, creates a more focused medical technologies leader and positions our company for meaningful value creation opportunities going forward,” Randle said.

The restructuring follows agreements to divest three business units — Acute Care, Interventional Urology, and OEM — which are now classified as discontinued operations.

Teleflex said the divestitures are expected to close in the second half of 2026.

The company plans to use most of the estimated $1.8 billion in after-tax proceeds from the transactions to repurchase shares and reduce debt.

READ:  Dorman Reports Higher 2025 Sales as Fourth-Quarter Earnings Decline

The restructuring program is expected to include workforce reductions and operational changes intended to eliminate costs associated with the divested businesses.

Teleflex said the program is expected to generate annual pre-tax savings of $48 million to $52 million once fully implemented.

The company expects restructuring activities to be substantially completed by mid-2028.

Teleflex also reported that cash and cash equivalents totaled $402.7 million at the end of 2025, compared with $285.3 million a year earlier.

The company’s board declared a quarterly dividend of $0.34 per share, payable March 31, 2026, to shareholders of record on March 6, 2026.

READ:  Universal Health Realty Income Trust Reports Lower Fourth-Quarter Earnings

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.